Clinical trial market in warmer climes

By agencies   |   Friday, 29 July 2005, 07:00 Hrs
Printer Print Email Email
HYDERABAD: India is set to emerge as a major player in the global market for third party clinical trials and a host of companies are increasingly engaging themselves in clinical trials of different magnitudes.

Though clinical trials of biotech and medicinal products for approval purposes are done usually in hospitals in India, there are many companies or agencies such as Ranbaxy, Eli Lilly, Asian Clinical Trials Ltd, among others, which are engaged in clinical trials.

According to industry experts, while the relatively low cost of the entire process in India is major attraction, the opportunities for Indian pharmaceutical and contract research organizations are now set for rise for a variety of reasons.

"The product patent protection will encourage multinational companies to import technology into India to develop new products. Indirectly, this will give boost to clinical trials market," P V Appaji, Executive Director, Pharmaceutical Export Promotion Council (Pharmexil), said.

SPOTLIGHT
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..